Sun Pharma rallies 5%, hits new 52-week high post Q3 results

The management said the company achieved a sustained momentum and good growth across businesses; despite rising costs, achieved higher profitability.

Shares of Sun Pharmaceutical Industries hit a 52-week high of Rs 879.85 on rallying 5.5 per cent on the BSE in Tuesday’s intra-day trade after the company reported a good operational performance in December quarter. Earnings before interest tax and depreciation and amortization (EBITDA) margins declined 80 bps year-on-year (YoY) at 26.4 per cent on back of marginal dip in gross margins and higher other expenditure.

The country’s largest pharma player posted an 11 per cent YoY rise in consolidated revenues to Rs 9,814.2 crore in Q3FY22, riding on strong growth in its key markets – India and the